# Safety and Efficacy Study of MT-2990 in Women With Endometriosis

> **NCT03840993** · PHASE2 · COMPLETED · sponsor: **Tanabe Pharma America, Inc.** · enrollment: 76 (actual)

## Conditions studied

- Endometrial Related Pain

## Interventions

- **DRUG:** MT-2990
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03840993
- **Lead sponsor:** Tanabe Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-15
- **Primary completion:** 2021-05-13
- **Final completion:** 2021-10-05
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03840993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03840993, "Safety and Efficacy Study of MT-2990 in Women With Endometriosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03840993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*